ArticleJournal of cancer research and clinical oncology2023

Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.

Harsh Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.